Back to results
TerminatedPhase 4

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

NCT01832350

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Barrow Neurological Institute

Phoenix, Arizona, United States

View on ClinicalTrials.gov
Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease — TrialFind